WUNRN
Conference Announcement/Call
for Abstracts
Reproductive Rights, New
Reproductive Technologies & The European Fertility Market
19-20 November 2015 - Venue:
Santander, Spain
INTRODUCTION
Since the first successfully
carried out IVF treatment in the 1970s, various new reproductive technologies
have been developed and applied for fertility treatment. These reproductive
innovations and the diversity in national regulation on reproductive technologies
have created a European fertility market, raising several questions, in terms
of medicine, law, ethics, policy and economics, dealing with:
- What are current and future
options of new reproductive technologies?
- Is it safe; what are the long
term health effects of artificial reproductive technologies on women and
children?
- Who has access: infertile,
lesbian/gay/trans couples, women undergoing chemotherapy, women who want to
delay childbearing, and/or couples who want to use PGD to screen against
disability or for sex; and what are the main barriers?
- Are fertility treatment
options covered by social health insurance or other means of public funding,
raising the question of equal access to reproductive technologies?
- Egg or sperm donation:
restricting the use of pre-embryos, compensation or not, and anonimisation of
the donor?
- Surrogacy contracts; Is there
a market for outsourcing pregnancy?
- What is the interface between
medically assisted reproduction and genetics, including preimplantation genetic
diagnosis (PGD) and preimplantation genetic screening (PGS)?
- Ethical challenges of
Direct-to-Consumer genetic testing and reproduction; human embryonic stem cells
and induced pluripotent stem cells
- Feminist ethics and reproductive
technologies: Contemporary issues
- What are the risks for
liability in the context of new reproductive technologies?
- Diversity in national
regulation on reproductive technologies gives rise to border crossing
‘reproductive tourism’; Is there a need to harmonise the European or
international market of reproductive technologies, and if so, how?
- What is the economic impact
of new reproductive technologies?
During
a 2 days conference, academics and professionals will meet, discussing the main
and latest developments in new reproductive technologies, from different
perspectives.
Confirmed Keynote speakers:
Dr. Joyce Harper
Professor in Human Genetics and
Embryology
Institute for Women’s Health
University College London
Professor Emily Jackson
Law Department
London School of Economics
London
Call for Abstracts
The conference has a
multidisciplinary approach inviting academics, professionals, students and
other interested persons to participate and submit an abstract for
presentation, addressing the above mentioned issues. The Conference main
objective is to explore different perspectives on new reproductive technologies
and exchanging ideas.
Those who wish to present
should send an abstract (max. 300 words) of their proposed presentation to the
Conference organisers before 1 October 2015. A short bibliography may be
attached on additional pages. The abstracts will be subjected to a peer review
process by the Conference’s Scientific Committee. Submissions will be reviewed
on a rolling basis (each submission will be reviewed within a short period from
its reception). Those who are selected are expected to present their paper at
the Conference to take place on 19-20 November at the University of Cantabria,
Santander. They will be given 15 minutes to present, plus 10 minutes for
questions.
A separate session for young
researchers is included.
An optional parallel session
(Spanish language) will be considered by the organisers.
Location: University of Cantabria, SANTANDER, SPAIN
Date: 19-20 November 2015
Conference fee: €100,-
Fee
waiver on request
Publication: Conference book
Conference participants will
receive a Book of Abstracts. Submitted papers will be considered for
publication in the Conference book, to be published afterwards.
Organisers
Erasmus University Rotterdam
(Netherlands) & GRIDES/FMV- University of Cantabria (Spain)
Contact: Andre den Exter:
denexter@bmg.eur.nl; Joaquin Cayon: joaquin.cayon@unican.es
Scientific Committee
Prof. Martin Buijsen, Erasmus
School of Law (chair)
Abstract submission, to:
buijsen@bmg.eur.nl
More info: www.erasmusobservatoryonhealthlaw.nl